GAO Finds "Personalized" Supplement Offers In DTC Genetic Testing Report
This article was originally published in The Tan Sheet
Executive Summary
An investigation into direct-to-consumer genetic testing products finds some firms marketing allegedly customized dietary supplement regimens to consumers based on their test results
You may also be interested in...
FDA To Regulate Direct-To-Consumer Genetic Tests
FDA sent letters to five genetic testing firms requesting pre-market submissions for the companies' already-marketed services, citing the need to prove that direct-to-consumer genetic assays are analytically and clinically accurate
Senate Supplement Hearing Spotlights Self-Regulation, FDA Enforcement
A Government Accountability Office investigation intended to shed light on whether senior citizens are at risk when buying herbal supplements has refueled debate on the effectiveness of both FDA enforcement and industry self-regulation
FDA Cites Long-Term Precedent In Blocking Retail Genetic Screening Plans
A particularly public pre-emptive stance by FDA's in vitro diagnostics oversight office halts Pathway Genomics' plans to start selling genetic screening test sample collection kits out of Walgreens stores, but the office's director stresses the move does not signal any changes to its enforcement policy for laboratory-developed tests